CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 50,000 shares at an average $3.07 ($153,513)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chairman and CEO acquired 9,257 shares (option exercise)
- 4 Grant or award Director acquired 27,322 shares (grant or award)
- 4 Grant or award Director acquired 27,322 shares (grant or award)
- 4 Grant or award Director acquired 27,322 shares (grant or award)
- 4 Open-market sale Director sold 79,456 shares at an average $3.73 ($296,225)
- 4 Open-market sale Director sold 2,724 shares at $3.88 ($10,564)
- 4 Open-market sale Director sold 6,003 shares at an average $3.94 ($23,668)
- 4/A Open-market sale Director sold 14,103 shares at an average $3.95 ($55,648)
- 4 Open-market sale Director sold 14,103 shares at an average $3.85 ($54,233)
- 4 Open-market sale Director sold 15,971 shares at $3.97 ($63,413)
- 4 Open-market sale Director sold 81,743 shares at an average $4.05 ($331,453)
- 4 Exercise or conversion Chief Accounting Officer acquired 15,000 shares (option exercise)
- 4 Gift Director gave 4,500 shares (gift)
- 4 Grant or award Director acquired 54,621 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 39,604 shares at $5.93 ($234,729)
- 4 Open-market sale Director sold 103,841 shares at an average $6.04 ($627,417)
Page 10 of 13 · 251 filings